Dimitri Khrakovsky is a Principal Scientist at Hexagon Bio since April 2024, with extensive experience in medicinal chemistry. Prior to this role, Dimitri served as a Senior Scientist II at Exelixis from June 2022 to March 2024, and as Lead Chemist at Engine Biosciences from May 2021 to June 2022. Dimitri worked at AbbVie for five years in various senior roles within medicinal chemistry, including Senior Scientist II and Senior Scientist I, from June 2016 to May 2021. The journey began at the University of California, Berkeley, where Dimitri was a Graduate Student Researcher from August 2011 to June 2016 while completing a Ph.D. in Organic Chemistry. Educational background includes a Bachelor’s Degree in Chemistry and Economics earned at the University of Chicago from 2007 to 2011, along with experience as a Safety Assessment Intern at Merck in the summer of 2010.
This person is not in any teams
This person is not in any offices